Xiao Li

2.6k total citations
142 papers, 1.6k citations indexed

About

Xiao Li is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Xiao Li has authored 142 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 34 papers in Molecular Biology and 26 papers in Cancer Research. Recurrent topics in Xiao Li's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and Cancer-related molecular mechanisms research (10 papers). Xiao Li is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (10 papers) and Cancer-related molecular mechanisms research (10 papers). Xiao Li collaborates with scholars based in China, United States and Belgium. Xiao Li's co-authors include Xinyong Liu, Peng Zhan, Erik De Clercq, Christophe Pannecouque, Jianni Qi, Qi Zhao, Wen‐Ming Chen, Di Zhang, Xuwang Chen and Wenrui Jin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Xiao Li

133 papers receiving 1.6k citations

Peers

Countries citing papers authored by Xiao Li

Since Specialization

Citations

This map shows the geographic impact of Xiao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao Li more than expected).

Fields of papers citing papers by Xiao Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao Li. The network helps show where Xiao Li may publish in the future.

Co-authorship network of co-authors of Xiao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao Li. A scholar is included among the top collaborators of Xiao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao Li. Xiao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dynamic contrast-enhanced ultrasound perfusion analysis for preoperative prediction of aggressive hepatocellular carcinoma subtypes 2025 ·Insights into Imaging ·(unknown), Xiao Li, Daohui Yang, Chong-Ke Zhao, (unknown), Yaqin Zhang, (unknown), (unknown), (unknown), Xinyuan Hu, (unknown), (unknown), Hui‐Xiong Xu, Lifan Wang	0
2	Xiaoer Huanglong pellets remodels the periphery microenvironment to improve attention deficit hyperactivity disorder based on the microbiota–gut–brain axis 2025 ·Phytomedicine ·Longtai You, (unknown), Jing Liu, Na Sai, Wen Zhao, Xiao Li, (unknown), Peng Guo, Jian Ni	0
3	Cost-effectiveness analysis of first-line tislelizumab plus chemotherapy for extensive-stage small cell lung cancer from the perspective of the healthcare system in China 2025 ·Frontiers in Public Health ·Fangfang Chen, Feng Xue, Xiao Li, Hong Tang, S. Joe Qin, Jie Peng, (unknown)	0
4	Circulating immune cell profile in patients with colorectal cancer 2024 ·British journal of surgery ·(unknown), (unknown), (unknown), (unknown), Qingxia Xu, Jiaguo Yu, Jiale Li, Xiao Li, Jingjing Duan, Haina Wang, Jian Ma, (unknown), Xin Zhang, Yuting Zhang, (unknown), Haiyi Liu, Xishan Wang	1
5	Treatment experience for different risk groups of Kaposiform hemangioendothelioma 2024 ·Frontiers in Oncology ·Miaomiao Li, Xusheng Wang, (unknown), (unknown), (unknown), (unknown), Bin Sun, Xiao Li, Yanlin Wang, Song Wang, Zhiyu Li, Luying Wang, (unknown), Feng Xue, Jianfeng Ge, (unknown), Ran Huo	2
6	Identification of neurotransmitter imbalances in the cingulate cortex of NMOSD patients using magnetic resonance spectroscopy 2024 ·Cerebral Cortex ·(unknown), Xiao Li, Fuyan Li, (unknown), Jing Wang, (unknown), Chuanchen Zhang, (unknown), Richard A.E. Edden, Fei Gao, (unknown), Fuxin Ren	2
7	Engineered Niobium Carbide MXenzyme-Integrated Self-Adaptive Coatings Inhibiting Periprosthetic Osteolysis by Orchestrating Osteogenesis–Osteoclastogenesis Balance 2024 ·ACS Applied Materials & Interfaces ·(unknown), Xiaoqing Lü, (unknown), (unknown), (unknown), Peng Wang, Jianing Liu, Zhibo Zhao, Xiao Li, Bin Liu, Kangqing Zuo, Zhentao Man, Ningbo Li, (unknown)	10
8	Comprehensive review of signaling pathways and therapeutic targets in gastrointestinal cancers 2024 ·Critical Reviews in Oncology/Hematology ·Pengfei Ji, Tingting Chen, Chao Li, (unknown), Xiao Li, Hong Zhu	2
9	Advancing Automatic Gastritis Diagnosis 2024 ·American Journal Of Pathology ·(unknown), Xixi Zeng, Linhao Qu, Xia Sheng, (unknown), (unknown), Bin Li, (unknown), Xiao Li, (unknown), Mei Dai, (unknown), (unknown), Weiqi Sheng, Dan Huang	1
10	Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation 2023 ·International Immunopharmacology ·(unknown), Jinchao Wang, Guangchuan Wang, Wanli Jiang, Zhen Li, (unknown), Junyong Zhang, (unknown), (unknown), Lifen Wang, (unknown), Lei Wu, Mingyan Zhang, Wenwen Wang, Xiao Li, Tong Mou, Chunqing Zhang, Qian Ding	9
11	SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis 2023 ·Pharmaceuticals ·(unknown), (unknown), Chao Cheng, (unknown), (unknown), Changjing Zuo, (unknown), Rou Li, Xiao Li	7
12	Lung adenocarcinoma manifesting as subsolid nodule potentially represents tumour in the equilibrium phase of immunoediting 2022 ·Immunology ·(unknown), Yi Ma, Hao Li, Xiao Li, Zewen Sun, (unknown), Ping Yin, Fan Yang, Mantang Qiu	4
13	Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer 2022 ·SHILAP Revista de lepidopterología ·Chen Li, Ana Ferro, Shivani K. Mhatre, (unknown), (unknown), Xiao Li, Li Shi, Simon Allen, Jayesh Desai, Marwan Fakih, Michael Cecchini, Katrina S. Pedersen, Tae You Kim, Irmarie Reyes‐Rivera, Neil H. Segal, (unknown)	13
14	Feasibility of 68Ga-Labeled Fibroblast Activation Protein Inhibitor PET/CT in Light-Chain Cardiac Amyloidosis 2022 ·JACC. Cardiovascular imaging ·Xuezhu Wang, (unknown), Yajuan Gao, Chao Ren, (unknown), Bowei Liu, Xiao Li, (unknown), Kaini Shen, Haiyan Ding, Hui Zhang, Zhuang Tian, Marcus Hacker, Yuanqiang Zhang, Yining Wang, Li J, Xiang Li, Li Huo	25
15	Impact of tumor deposits on the prognosis and chemotherapy efficacy in stage III colorectal cancer patients with different lymph node status: A retrospective cohort study in China 2018 ·International Journal of Surgery ·Xiao Li, (unknown), Qi Zhao, Jianni Qi, Wenwen Wang, Di Zhang, Zhen Li, Chengyong Qin	16
16	Combined fibrinogen and neutrophil–lymphocyte ratio as a predictive factor in resectable colorectal adenocarcinoma 2018 ·Cancer Management and Research ·Xiao Li, (unknown), Qi Zhao, Jianni Qi, Wenwen Wang, Di Zhang, Zhen Li, Chengyong Qin	17
17	Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients 2018 ·Cancer Management and Research ·Xiao Li, Qi Zhao, (unknown), Jianni Qi, Wenwen Wang, Di Zhang, Zhen Li, Chengyong Qin	11
18	[A systematic review of international simulation models on the natural history of breast cancer: current understanding and challenges for Chinese-population-specific model development]. 2017 ·PubMed ·(unknown), Le Wang, Jufang Shi, Jianming Ying, Juan Zhu, Lili Chen, (unknown), Jiyong Gong, Xiao Li, Jialin Wang, Min Dai	1
19	Reduction of Dicer1 By Multiple Myeloma Cells in Mesenchymal Stem Cells Promotes Cellular Senescence and Tumor-Supporting Effect and Decreases the Differentiation 2017 ·Blood ·Juan Guo, Xiao Li, Youshan Zhao, Chengming Fei, Chunkang Chang, Sida Zhao, (unknown)	3
20	Treatment-Related MR Imaging Findings in Patients with Glioma after Radiotherapy, Chemotherapy, and Biological Therapy 2016 ·Xiao Li, Fanny Morón	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact